Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Chambaz

Showing results (51-60 of 56) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 56 results.
British Journal of Haematology|February 1, 1996
Unmaintained cytogenetic and molecular remission in chronic myelogenous leukaemia following treatment by interferonB Rio, S Ramond, J M Lacorte, et al.
Biochemistry|October 10, 2001
Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-IID Pastier, S Dugué, E Boisfer, et al.
European Journal of Biochemistry|December 15, 1996
Lipid-binding properties of synthetic peptide fragments of human apolipoprotein A-IIC Benetollo, G Lambert, C Talussot, et al.
The Journal of Biological Chemistry|February 13, 1999
The -700/-310 fragment of the apolipoprotein A-IV gene combined with the -890/-500 apolipoprotein C-III enhancer is sufficient to direct a pattern of gene expression similar to that for the endogenous apolipoprotein A-IV geneJ Le Beyec, V Chauffeton, H Y Kan, et al.
The Journal of Biological Chemistry|April 17, 1999
Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysisE Boisfer, G Lambert, V Atger, et al.
Nature|April 16, 1998
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunctionK Clément, C Vaisse, N Lahlou, et al.
Pageof 6

Showing results (51-60 of 56) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 56 results.
British Journal of Haematology|February 1, 1996
Unmaintained cytogenetic and molecular remission in chronic myelogenous leukaemia following treatment by interferonB Rio, S Ramond, J M Lacorte, et al.
Biochemistry|October 10, 2001
Apolipoprotein A-II/A-I ratio is a key determinant in vivo of HDL concentration and formation of pre-beta HDL containing apolipoprotein A-IID Pastier, S Dugué, E Boisfer, et al.
European Journal of Biochemistry|December 15, 1996
Lipid-binding properties of synthetic peptide fragments of human apolipoprotein A-IIC Benetollo, G Lambert, C Talussot, et al.
The Journal of Biological Chemistry|February 13, 1999
The -700/-310 fragment of the apolipoprotein A-IV gene combined with the -890/-500 apolipoprotein C-III enhancer is sufficient to direct a pattern of gene expression similar to that for the endogenous apolipoprotein A-IV geneJ Le Beyec, V Chauffeton, H Y Kan, et al.
The Journal of Biological Chemistry|April 17, 1999
Overexpression of human apolipoprotein A-II in mice induces hypertriglyceridemia due to defective very low density lipoprotein hydrolysisE Boisfer, G Lambert, V Atger, et al.
Nature|April 16, 1998
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunctionK Clément, C Vaisse, N Lahlou, et al.
Pageof 6